BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6337107)

  • 1. Peroral immunization of healthy adults with live Escherichia coli O4K12 bacteria. Antibody response as measured in serum and secretions.
    Kaijser B
    Int Arch Allergy Appl Immunol; 1983; 70(2):164-8. PubMed ID: 6337107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
    Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
    Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
    Kaijser B; Larsson P; Olling S
    Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response in mice immunized by mucosal routes with formalin-inactivated enteropathogenic Escherichia coli (EPEC) strains.
    Drago-Serrano ME; Manjarréz Hernandez HA; Gavilanes Parra S; Sainz Espuñes Tdel R
    Rev Latinoam Microbiol; 2004; 46(1-2):17-23. PubMed ID: 17061522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies in Escherichia coli urinary tract infection.
    Fries D; Delavelle F; Mathieu D; Jacques L; Renault L
    Proc Eur Dial Transplant Assoc; 1977; 14():535-40. PubMed ID: 341144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of Escherichia coli antibodies in urinary tract infection: a review and perspective.
    Neter E
    Kidney Int Suppl; 1975 Aug; 4():S23-7. PubMed ID: 1104978
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of O antigens and antibodies during urinary tract infections due to Escherichia coli (author's transl)].
    Fries D; Renault L; Mathieu D; Charpentier B; Guerin D; Jacques L
    Nouv Presse Med; 1979 Mar; 8(15):1239-43. PubMed ID: 375188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
    Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
    J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis.
    Kaijser B; Larsson P; Nimmich W; Söderström T
    Prog Allergy; 1983; 33():275-88. PubMed ID: 6187016
    [No Abstract]   [Full Text] [Related]  

  • 11. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
    Smith JW; Kaijser B
    J Clin Invest; 1976 Aug; 58(2):276-81. PubMed ID: 783196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood.
    Mellander L; Carlsson B; Hanson LA
    J Pediatr; 1984 Apr; 104(4):564-8. PubMed ID: 6200589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
    Ahlstedt S; Kaijser B
    Immunology; 1975 May; 28(5):841-6. PubMed ID: 1093966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The host-parasite relationship in urinary tract infections.
    Hanson LA; Ahlstedt S; Jodal U; Kaijser B; Larsson P; Lidin-Janson G; Lincoln K; Lindberg U; Mattsby I; Olling S; Peterson H; Sohl A
    Kidney Int Suppl; 1975 Aug; 4():S28-34. PubMed ID: 1104979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
    Shimauchi H
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of specific antibody-secreting cells in salivary glands of BALB/c mice following parenteral or oral immunization with Porphyromonas gingivalis fimbriae.
    Kusumoto Y; Ogawa T; Hamada S
    Arch Oral Biol; 1993 May; 38(5):361-7. PubMed ID: 8101076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary immunoglobulins in healthy individuals and children with acute pyelonephritis.
    Svanborg Edén C; Kulhavy R; Mårild S; Prince SJ; Mestecky J
    Scand J Immunol; 1985 Apr; 21(4):305-13. PubMed ID: 3890147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E; Naumann G; Broschewitz U
    Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibody response to P-fimbriae of Escherichia coli in patients with genitourinary infections].
    Kanai S; Miyake K; Agata N; Ohta M; Kato N
    Hinyokika Kiyo; 1990 Jan; 36(1):1-6. PubMed ID: 1968696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.